Postoperative stroke and neurological outcomes in the early phase after revascularization surgeries for moyamoya disease: an age-stratified comparative analysis

Y Araki, K Yokoyama, K Uda, F Kanamori… - Neurosurgical …, 2021 - Springer
Stroke and neurological outcomes in the early phase following revascularization for
moyamoya disease (MMD) may depend on the patient's age. In this study, an age-stratified …

Late cerebrovascular events and social outcome after adolescence: long-term outcome of pediatric moyamoya disease

T Funaki, JC Takahashi, S Miyamoto - Neurologia medico-chirurgica, 2018 - jstage.jst.go.jp
In this article, the authors review the literature related to long-term outcome of pediatric
moyamoya disease, focusing on late cerebrovascular events and social outcome of pediatric …

Association between white matter impairment and cognitive dysfunction in patients with ischemic Moyamoya disease

Z Liu, S He, Z Xu, R Duan, L Yuan, C Xiao, Z Yi… - BMC neurology, 2020 - Springer
Abstract Background Ischemic Moyamoya disease is one of the important causes of stroke,
which leads to severe impairment in cognitive functions. This cognitive impairment occurs …

Changes in cerebral blood flow in the postoperative chronic phase after combined cerebral revascularization for moyamoya disease with ischaemic onset

Y Araki, T Mamiya, N Fujita, K Uda, K Yokoyama… - Neurosurgical …, 2022 - Springer
The purpose of this study was to examine the effects of combined revascularization for
ischaemic-onset moyamoya disease (MMD) on cerebral haemodynamics by comparing …

[HTML][HTML] Preservation of spatial memory and neuroprotection by the fatty acid amide hydrolase inhibitor URB597 in a rat model of vascular dementia

DP Wang, Q Lin, K Kang, YF Wu, SH Su… - Annals of Translational …, 2021 - ncbi.nlm.nih.gov
Background Chronic cerebral hypoperfusion (CCH) is a major risk factor for vascular
dementia (VaD). There are currently no broadly effective prevention or treatment strategies …

Different aspects of cognitive function in adult patients with moyamoya disease and its clinical subtypes

Z Shi, YJ Wen, Z Huang, LB Yu, D Zhang - Stroke and Vascular …, 2020 - svn.bmj.com
Objective Although a few reports suggested that cognitive function impairment could be
found in adult patients with moyamoya disease (MMD), there were still many aspects that …

Characterizing the neurocognitive profiles of children with moyamoya disease using the Das Naglieri cognitive assessment system

Y Kusano, T Funaki, K Ueda, N Nishida, K Tanaka… - Scientific Reports, 2022 - nature.com
Although cognitive impairment is well-documented in children with moyamoya disease
(MMD), selective decline in specific neurocognitive domains remains controversial. The …

Different aspects of dysexecutive syndrome in patients with moyamoya disease and its clinical subtypes

L Fang, J Huang, Q Zhang, RCK Chan, R Wang… - Journal of …, 2016 - thejns.org
OBJECTIVE Dysexecutive syndrome is common in patients with moyamoya disease (MMD),
a chronic cerebrovascular disease that is characterized by stenosis of the bilateral internal …

Predictors of preoperative cognitive dysfunction in adults with Moyamoya disease: a preliminary research

J Sun, Z Shi, L Yu, Y Wen, D Zhang - BMC neurology, 2022 - Springer
Objective To explore potential risk factors of preoperative cognitive dysfunction in adult
patients with moyamoya disease (MMD) and discuss significance of moyamoya vessels …

Cognitive dysfunction survey of the Japanese patients with moyamoya disease (COSMO-JAPAN study): study protocol

Y Takagi, S Miyamoto… - Neurologia medico …, 2015 - jstage.jst.go.jp
Moyamoya disease is a cerebrovascular occlusive disease characterized by progressive
stenosis or by occlusion at the terminal portion of the bilateral internal carotid arteries. The …